Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

Background: Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adherence, and healthcare resource utilization (HRU) and cost...

Full description

Bibliographic Details
Main Authors: Chue, P. (Author), Dursun, S.M (Author), Guigue, A. (Author), Klarenbach, S.W (Author), Luu, H. (Author), Martins, K.J.B (Author), Richer, L. (Author), Snaterse, M. (Author), So, H. (Author), Vu, K. (Author), Wong, K.O (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Administrative data
Antipsychotics
Community treatment order
Healthcare cost
Healthcare resource utilization
Long-acting injection
Retrospective
Schizophrenia
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items